The link between lymphatic function and adipose biology

Annals of the New York Academy of Sciences

Volumn 1131, Issue , 2008, Pages 82-88

  Harvey, Natasha L ^a,b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b HANSON INSTITUTE   (Australia)

Author keywords

Adipogenesis; Inflammation; Lymph; Lymph node; Lymphangiogenesis; Lymphatic; Obesity

Indexed keywords

ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL MODEL; BIOLOGY; CONFERENCE PAPER; INFLAMMATION; LIPID ABSORPTION; LIPID TRANSPORT; LYMPH NODE; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM DISEASE; NONHUMAN; VASCULAR DISEASE;

EID: 44449086848     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1413.007     Document Type: Conference Paper

References (55)

1. Lord, R.S. 1968. The white veins: conceptual difficulties in the history of the lymphatics. Med. Hist. 12 : 174 184.
2. Yoffey, J.M. & F.C. Courtice. 1970. Lymphatics, Lymph and the Lymphomyeloid Complex. Academic Press. London-New York.
3. Asellius, G. 1627. De lactibus sive lacteis venis. Mediolani. Milan.
4. Pond, C.M. & C.A. Mattacks. 1995. Interactions between adipose tissue around lymph nodes and lymphoid cells in vitro. J. Lipid. Res. 36 : 2219 2231.
5. Pond, C.M. & C.A. Mattacks. 1998. In vivo evidence for the involvement of the adipose tissue surrounding lymph nodes in immune responses. Immunol. Lett. 63 : 159 167.
6. Pond, C.M. & C.A. Mattacks. 2003. The source of fatty acids incorporated into proliferating lymphoid cells in immune-stimulated lymph nodes. Br. J. Nutr. 89 : 375 383.
7. Mattacks, C.A., D. Sadler & C.M. Pond. 2004. Site-specific differences in fatty acid composition of dendritic cells and associated adipose tissue in popliteal depot, mesentery, and omentum and their modulation by chronic inflammation and dietary lipids. Lymphat. Res. Biol. 2 : 107 129.
8. Pond, C.M. & C.A. Mattacks. 2002. The activation of the adipose tissue associated with lymph nodes during the early stages of an immune response. Cytokine 17 : 131 139.
9. Mattacks, C.A., D. Sadler & C.M. Pond. 2003. The cellular structure and lipid/protein composition of adipose tissue surrounding chronically stimulated lymph nodes in rats. J. Anat. 202 : 551 561.
10. Pond, C.M. 2003. Paracrine relationships between adipose and lymphoid tissues: implications for the mechanism of HIV-associated adipose redistribution syndrome. Trends Immunol. 24 : 13 18.
11. Eberl, G. et al. 2004. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5 : 64 73.
12. Rockson, S.G. 2000. Lymphedema. Curr. Treat. Options Cardiovasc. Med. 2 : 237 242.
13. Witte, M.H. et al. 2001. Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology. Microsc. Res. Tech. 55 : 122 145.
14. Karkkainen, M.J. et al. 2000. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat. Genet. 25 : 153 159.
15. Irrthum, A. et al. 2000. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am. J. Hum. Genet. 67 : 295 301.
16. Fang, J. et al. 2000. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am. J. Hum. Genet. 67 : 1382 1388.
17. Finegold, D.N. et al. 2001. Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum. Mol. Genet. 10 : 1185 1189.
18. Bell, R. et al. 2001. Analysis of lymphoedema-distichiasis families for FOXC2 mutations reveals small insertions and deletions throughout the gene. Hum. Genet. 108 : 546 551.
19. Irrthum, A. et al. 2003. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema- telangiectasia. Am. J. Hum. Genet. 72 : 1470 1478.
20. Petrek, J.A., P.I. Pressman & R.A. Smith. 2000. Lymphedema: current issues in research and management. CA Cancer J. Clin. 50 : 292 307 quiz 308-311.
21. Beesley, V. et al. 2007. Lymphedema after gynecological cancer treatment : prevalence, correlates, and supportive care needs. Cancer 109 : 2607 14.
22. World Health Organization. 2000. Lymphatic filariasis. http://www.who.int.
23. Ryan, T.J. 1995. Lymphatics and adipose tissue. Clin. Dermatol. 13 : 493 498.
24. Tavakkolizadeh, A., K.Q. Wolfe & L. Kangesu. 2001. Cutaneous lymphatic malformation with secondary fat hypertrophy. Br. J. Plast. Surg. 54 : 367 369.
25. Harwood, C.A. et al. 1996. Lymphatic and venous function in lipoedema. Br. J. Dermatol. 134 : 1 6.
26. Brautigam, P. et al. 1998. Analysis of lymphatic drainage in various forms of leg edema using two compartment lymphoscintigraphy. Lymphology 31 : 43 55.
27. Bilancini, S. et al. 1995. Functional lymphatic alterations in patients suffering from lipedema. Angiology 46 : 333 339.
28. Amann-Vesti, B.R., U.K. Franzeck & A. Bollinger. 2001. Microlymphatic aneurysms in patients with lipedema. Lymphology 34 : 170 175.
29. Karkkainen, M.J. et al. 2001. A model for gene therapy of human hereditary lymphedema. Proc. Natl. Acad. Sci. USA 98 : 12677 12682.
30. Harvey, N.L. et al. 2005. Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat. Genet. 37 : 1072 1081.
31. Wigle, J.T. & G. Oliver. 1999. Prox1 function is required for the development of the murine lymphatic system. Cell 98 : 769 778.
32. Wigle, J.T. et al. 2002. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 21 : 1505 1513.
33. Nougues, J., Y. Reyne & J.P. Dulor. 1988. Differentiation of rabbit adipocyte precursors in primary culture. Int. J. Obes. 12 : 321 333.
34. Hotamisligil, G.S. 2006. Inflammation and metabolic disorders. Nature 444 : 860 867.
35. Hotamisligil, G.S., N.S. Shargill & B.M. Spiegelman. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 : 87 91.
36. Samad, F. et al. 1997. Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Mol. Med. 3 : 37 48.
37. Fried, S.K., D.A. Bunkin & A.S. Greenberg. 1998. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83 : 847 850.
38. Sartipy, P. & D.J. Loskutoff. 2003. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 100 : 7265 7270.
39. Hamilton, B.S. et al. 1995. Increased obese mRNA expression in omental fat cells from massively obese humans. Nat. Med. 1 : 953 956.
40. Leibovich, S.J. et al. 1987. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329 : 630 632.
41. Sierra-Honigmann, M.R. et al. 1998. Biological action of leptin as an angiogenic factor. Science 281 : 1683 1686.
42. Rega, G. et al. 2007. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo. Arterioscler. Thromb. Vasc. Biol. 27 : 1587 1595.
43. Weisberg, S.P. et al. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 : 1796 1808.
44. Xu, H. et al. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 : 1821 1830.
45. Berse, B. et al. 1992. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell. 3 : 211 220.
46. Schoppmann, S.F. et al. 2002. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol. 161 : 947 956.
47. Cursiefen, C. et al. 2004. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113 : 1040 1050.
48. Cho, C.H. et al. 2007. Angiogenic role of LYVE-1-positive macrophages in adipose tissue. Circ. Res. 100 : e47 e57.
49. Kunstfeld, R. et al. 2004. Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. Blood 104 : 1048 1057.
50. Baluk, P. et al. 2005. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J. Clin. Invest. 115 : 247 257.
51. Rupnick, M.A. et al. 2002. Adipose tissue mass can be regulated through the vasculature. Proc. Natl. Acad. Sci. USA 99 : 10730 10735.
52. Kolonin, M.G. et al. 2004. Reversal of obesity by targeted ablation of adipose tissue. Nat. Med. 10 : 625 632.
53. Brakenhielm, E. et al. 2004. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ. Res. 94 : 1579 1588.
54. Fogt, F. et al. 2004. Observation of lymphatic vessels in orbital fat of patients with inflammatory conditions: a form fruste of lymphangiogenesis? Int. J. Mol. Med. 13 : 681 683.
55. Backhed, F. et al. 2007. Postnatal lymphatic partitioning from the blood vasculature in the small intestine requires fasting-induced adipose factor. Proc. Natl. Acad. Sci. USA 104 : 606 611.